PT Kalbe Farma Tbk. (PTKFY)

Market Cap	2.98B -18.2%
Revenue (ttm)	2.06B +7.0%
Net Income	209.31M +13.4%
EPS	0.00 +14.7%
Shares Out	n/a
PE Ratio	14.25
Forward PE	13.17
Dividend	0.28 (2.09%)
Ex-Dividend Date	Jun 6, 2025

Volume	n/a
Average Volume	507
Open	13.57
Previous Close	13.57
Day's Range	13.57 - 13.57
52-Week Range	11.44 - 21.16
Beta	n/a
RSI	45.67
Earnings Date	Mar 27, 2026

About PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company pro...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1966
• Employees: 12,784
• Stock Exchange: OTCMKTS
• Ticker Symbol: PTKFY

Financial Performance

In 2024, PT Kalbe Farma Tbk.'s revenue was 32.63 trillion, an increase of 7.16% compared to the previous year's 30.45 trillion. Earnings were 3.24 trillion, an increase of 17.13%.

Financial numbers in IDR